As a specialist contract research organisation, Pharmaterials provides its clients with a comprehensive package of advanced solid-state screening (polymorph, salts, co-crystals and amorphous forms), characterisation and interpretation services to support the development of new and existing active drug substances and drug product formulations.
Using state-of-the-art technologies in salt selection, polymorphism screening and physical form characterisation, we are able to capture all relevant information very rapidly with minimal drug substance per experiment. This means that we can support all of your screening needs, no matter what stage of the drug development process you are in.
Whilst our systems are high throughput all stages are manually controlled allowing human intervention and observation by highly skilled scientists to maximise the return from each experiment.
Within the area of physical testing we have a clear philosophy: "We don't just measure - we understand". We talk with our customers, based on our experience we understand their needs and work with them to provide the best solution.
The Pharmaterials Advantage: We offer a range of services fitted to your needs, with the communication and advice that you need to move your project forward. With £1m of investment, including our industry leading transmission X-ray powder diffraction with 96 well plate and 96 well plate reading Raman microscope we have state-of-the-art instrumentation. Multiple DSC, TGA and GVS instruments give vast capacity, a wealth of supporting services and robotics allow us to provide an excellent and rapid service at great value. Our staff are outstanding and dedicated to provide the help you need to inform your choices.